ELTX Next Earnings Date Notes

— Elicio Therapeutics (ELTX) is a clinical-stage biotechnology company focused on developing immunotherapies to treat cancer, utilizing its Amphiphile (AMP) platform to enhance the delivery & efficacy of cancer vaccines and immunotherapeutics. Their lead candidate, ELI-002, is an innovative AMP-based vaccine targeting KRAS-driven tumors, a notoriously difficult challenge in oncology. For investors tracking Elicio, the most relevant metrics are clinical trial progress (especially for ELI-002 in Phase 1/2 trials), data on safety & efficacy, updates on enrollment & dosing milestones, and regulatory feedback. Since Elicio is pre-revenue, financial indicators like cash runway, R&D expenses, partnerships, and grant funding are crucial to assess operational sustainability. On earnings calls, pay close attention to management's updates on trial readouts, guidance on next clinical milestones, and commentary about partnership or licensing activity. Ultimately, Elicio's long-term performance hinges on translating its AMP platform's potential into tangible clinical benefits, securing sufficient funding, and advancing its pipeline efficiently toward regulatory approval. The next projected earnings date for ELTX is 8/18/2026 after close (stay tuned for a confirmed earnings date once announced).

Elicio Therapeutics Next Earnings Date FAQ

On this page we presented the Elicio Therapeutics Next Earnings Date information for Elicio Therapeutics along with recent past earnings dates. For Q1 of 2026, ELTX reported earnings of -0.650/share, with the earnings report taking place on 5/11/2026. For Q4 of 2025, ELTX reported earnings of /share, with the earnings report taking place on 3/30/2026. For Q4 of 2025, ELTX reported earnings of -0.450/share, with the earnings report taking place on 3/12/2026. For Q3 of 2025, ELTX reported earnings of -0.600/share, with the earnings report taking place on 11/13/2025. For Q2 of 2025, ELTX reported earnings of -0.660/share, with the earnings report taking place on 8/7/2025. Based on these past earnings dates, the projected next earnings date for ELTX is 8/18/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Elicio Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Elicio Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Elicio Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next ELTX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up ELTX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the ELTX next earnings date.